189 related articles for article (PubMed ID: 28962610)
21. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
22. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
23. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
Cooper CL; Davis HL; Angel JB; Morris ML; Elfer SM; Seguin I; Krieg AM; Cameron DW
AIDS; 2005 Sep; 19(14):1473-9. PubMed ID: 16135900
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
[TBL] [Abstract][Full Text] [Related]
25. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of vaccination against hepatitis B in HIV infected children].
Ołdakowska A; Marczyńska M; Szczepańska-Putz M; Kowalik-Mikołajewska B
Przegl Epidemiol; 2004; 58 Suppl 1():129-33. PubMed ID: 15807171
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
[TBL] [Abstract][Full Text] [Related]
28. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy.
Lao-araya M; Puthanakit T; Aurpibul L; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Jul; 25(29):5324-9. PubMed ID: 17566615
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
30. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
31. Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.
Allen K; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK; Okulicz JF
BMC Infect Dis; 2015 May; 15():203. PubMed ID: 25928043
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
[TBL] [Abstract][Full Text] [Related]
33. Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.
Chaiklang K; Wipasa J; Chaiwarith R; Praparattanapan J; Supparatpinyo K
PLoS One; 2013; 8(11):e80409. PubMed ID: 24265819
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity.
Makhlouf NA; Farghaly AM; Zaky S; Rashed HA; Abu Faddan NH; Sayed D; El-Badawy O; Afifi N; Hamza WS; El-Sayed Y
J Med Virol; 2016 Sep; 88(9):1567-75. PubMed ID: 26910304
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal.
Beghin JC; Ruelle J; Sokal E; Bachy A; Krishna M; Hall L; Goubau P; Van der Linden D
J Med Virol; 2017 Jan; 89(1):182-185. PubMed ID: 27291342
[TBL] [Abstract][Full Text] [Related]
36. Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial.
Jain P; Dewan P; Gomber S; Kashyap B; Raizada A
Indian Pediatr; 2021 Mar; 58(3):224-228. PubMed ID: 33713056
[TBL] [Abstract][Full Text] [Related]
37. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.
Simani OE; Izu A; Violari A; Cotton MF; van Niekerk N; Adrian PV; Madhi SA
AIDS; 2014 Feb; 28(4):531-41. PubMed ID: 24468996
[TBL] [Abstract][Full Text] [Related]
38. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
39. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
40. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
